University of Adelaide-led Virus Research Team Introduces T-Cell based Zika Vaccine Advances

University of Adelaide-led Virus Research Team Introduces T-Cell based Zika Vaccine Advances

University of Adelaide affiliated researchers have made significant advances in developing a novel vaccine against Zika virus. The vaccine candidate could possibly lead to global eradication of the disease. A breakthrough, it is the first T-cell based investigational Zika vaccine. The team has more preclinical research left to ready for the right clinical trials partner to then commercialize.

Background

The Australian-based virology team, led by Professor Eric Gowans and Dr. Branka Grubor-Bauk from the Basil Hetzel Institute for Translational Health Research, and supported by the Hospital Research Foundation—has developed a vaccine that the team reports prevents Zika infection in pre-clinical models of the disease. The team’s recent findings are now published in the international journal Science Advance.

What is Zika?

A mosquito-transmitted ‘flavivirus’ that can cause microcephaly (a birth defect where a baby’s head is significantly smaller than expected) and severe birth defects in infants born to infected mothers. Hence, the introduction of a successful Zika vaccine could help prevent infection of pregnant women and the resultant congenital effects in the unborn chil...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee